ContraFect Corporation (CFRXQ)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 32.53 Million USD | 87.11% |
| 2021 | 17.38 Million USD | -54.84% |
| 2020 | 38.49 Million USD | 97.78% |
| 2019 | 19.46 Million USD | -28.78% |
| 2018 | 27.33 Million USD | 43.88% |
| 2017 | 18.99 Million USD | 4.88% |
| 2016 | 18.11 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 20.36 Million USD | -14.05% |
| 2023 Q1 | 23.68 Million USD | -27.18% |
| 2023 Q3 | 14.88 Million USD | -26.89% |
| 2022 Q1 | 26.04 Million USD | 49.79% |
| 2022 Q2 | 27.91 Million USD | 7.18% |
| 2022 Q4 | 32.53 Million USD | 24.46% |
| 2022 Q3 | 26.13 Million USD | -6.36% |
| 2021 Q3 | 24.83 Million USD | 0.0% |
| 2021 Q4 | 17.38 Million USD | -30.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -118483.458% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -243.664% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 55.112% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -3922.161% |
| Rebus Holdings, Inc. | 5.24 Million USD | -520.584% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 44.876% |
| Qrons Inc. | 1.48 Million USD | -2085.176% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 1.22 Million USD | -2552.965% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 56.579% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -72682.799% |
| Skye Bioscience, Inc. | 14.07 Million USD | -131.172% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 38.972% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -239.5% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -7616.667% |
| SQZ Biotechnologies Company | 50.03 Million USD | 34.989% |
| Intellipharmaceutics International Inc. | 12 Million USD | -170.894% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -744.649% |
| Mesoblast Limited | 188.44 Million USD | 82.737% |
| Marizyme, Inc. | 26.67 Million USD | -21.95% |
| Genus plc | 485 Million USD | 93.293% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -456.788% |
| Pharming Group N.V. | 244.07 Million USD | 86.672% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -1518.353% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -1192.796% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -756.079% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -1541.895% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -749.895% |
| IMV Inc. | 37.93 Million USD | 14.24% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -176.197% |
| MultiCell Technologies, Inc. | 1617.67 USD | -2010878.753% |
| ONE Bio Corp. | 27.49 Million USD | -18.313% |
| Accustem Sciences Inc. | 1.07 Million USD | -2914.254% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 57.98% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -1438.059% |
| Q BioMed Inc. | 8.13 Million USD | -299.991% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 60.775% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -532.157% |
| Biomind Labs Inc. | 1.49 Million USD | -2070.742% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 72.599% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -259.769% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -76.766% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -2168.769% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -22793.839% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -16075.242% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -466.168% |
| GB Sciences, Inc. | 5.41 Million USD | -500.474% |
| Alpha Cognition Inc. | 7.16 Million USD | -354.041% |
| HST Global, Inc. | 593.59 Thousand USD | -5380.354% |
| CSL Limited | 18.62 Billion USD | 99.825% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -2483.48% |
| Halberd Corporation | 728.71 Thousand USD | -4364.135% |
| Enzolytics Inc. | 365.26 Million USD | 91.094% |
| Agentix Corp. | 2.51 Million USD | -1195.769% |
| Resverlogix Corp. | 67.39 Million USD | 51.732% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -3778.593% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 92.689% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -1797.958% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -31.459% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -173.299% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -787.573% |
| AVAX Technologies, Inc. | 3.99 Million USD | -714.549% |
| Zenith Capital Corp. | 27.56 Thousand USD | -117898.477% |
| Genscript Biotech Corporation | 1.32 Billion USD | 97.546% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -13531.031% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -771.139% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -4678.11% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -1099.679% |
| Kadimastem Ltd | 3.5 Million USD | -828.166% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -48505.238% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 35.28% |
| BioStem Technologies, Inc. | 15.9 Million USD | -104.537% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -6900.445% |
| LadRx Corporation | 2.2 Million USD | -1378.327% |
| Cell Source, Inc. | 15.8 Million USD | -105.805% |
| Regen BioPharma, Inc. | 5.45 Million USD | -496.066% |
| Regen BioPharma, Inc. | 5.45 Million USD | -496.066% |
| NovAccess Global Inc. | 7.86 Million USD | -313.842% |
| Affymax, Inc. | 8.87 Million USD | -266.712% |
| Itoco Inc. | 1.65 Million USD | -1867.818% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -1485.668% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -437.791% |
| Mobile Lads Corp. | 1.31 Million USD | -2376.671% |
| CytoDyn Inc. | 127.89 Million USD | 74.564% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -77727.221% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -1976.831% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -194.524% |
| SYBLEU INC | 681.41 Thousand USD | -4674.05% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -433.129% |
| International Stem Cell Corporation | 5.27 Million USD | -516.468% |
| Bioxytran, Inc. | 3.24 Million USD | -901.108% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -5098.231% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -604.573% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 20.648% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -46.108% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -1506.162% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -493.848% |
| Neutra Corp. | 973.52 Thousand USD | -3241.554% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -12.118% |
| PureTech Health plc | 125.58 Million USD | 74.096% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -765.848% |
| IXICO plc | 1.9 Million USD | -1611.895% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -58.464% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 68.516% |
| CSL Limited | 18.62 Billion USD | 99.825% |
| Cellectis S.A. | 249.36 Million USD | 86.955% |